Rohto-Mentholatum (Vietnam) Co., Ltd. FDA Record
- Latest inspection OAI · Apr 14, 2026
- Last warning letter 2026
Rohto-Mentholatum (Vietnam) Co., Ltd. has 8 FDA recalls, 5 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Rohto-Mentholatum (Vietnam) Co., Ltd., the most recent on Oct 14, 2026.
- Latest recall
- D-0719-2026 · Class II · Jul 14, 2026
- Latest inspection
- Apr 14, 2026 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 8 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 5 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Rohto-Mentholatum (Vietnam) Co., Ltd.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 1 | 1 | 8 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Rohto-Mentholatum (Vietnam) Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Rohto-Mentholatum (Vietnam) Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Rohto-Mentholatum (Vietnam) Co., Ltd. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Oct 14, 2026 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0719-2026 | Class II | Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL… | Jul 14, 2026 |
| D-0722-2026 | Class II | Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%)… | Jul 14, 2026 |
| D-0718-2026 | Class II | Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol… | Jul 14, 2026 |
| D-0717-2026 | Class II | Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%)… | Jul 14, 2026 |
| D-0716-2026 | Class II | Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%)… | Jul 14, 2026 |
| D-0715-2026 | Class II | Rohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0.05%, zinc sulfate… | Jul 14, 2026 |
| D-0721-2026 | Class II | Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, TWIN PACK 0.34 FL… | Jul 14, 2026 |
| D-0720-2026 | Class II | Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10… | Jul 14, 2026 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 14, 2026 | Ho Chi Minh, Vietnam | Drugs | Official Action Indicated (OAI) | 3008808745 |
| Nov 1, 2019 | Ho Chi Minh, Vietnam | Drugs | Voluntary Action Indicated (VAI) | 3008808745 |
| Mar 16, 2018 | Ho Chi Minh, Vietnam | Drugs | Voluntary Action Indicated (VAI) | 3008808745 |
| Apr 14, 2015 | Ho Chi Minh, Vietnam | Drugs | Voluntary Action Indicated (VAI) | 3008808745 |
| May 15, 2012 | Ho Chi Minh, Vietnam | Drugs | Official Action Indicated (OAI) | 3008808745 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Rohto-Mentholatum (Vietnam) Co., Ltd.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3008808745 | Ho Chi Minh, Vietnam | 5 | Apr 14, 2026 |
Rohto-Mentholatum (Vietnam) Co., Ltd. and the FDA: common questions
Has Rohto-Mentholatum (Vietnam) Co., Ltd. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Rohto-Mentholatum (Vietnam) Co., Ltd.. The most recent is dated Oct 14, 2026.
Has Rohto-Mentholatum (Vietnam) Co., Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Rohto-Mentholatum (Vietnam) Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Rohto-Mentholatum (Vietnam) Co., Ltd.?
The most recent FDA inspection on file ended Apr 14, 2026 at Ho Chi Minh, Vietnam and was classified OAI. FDA has 5 inspections of Rohto-Mentholatum (Vietnam) Co., Ltd. on file, 2 of them classified OAI (official action indicated).
Has Rohto-Mentholatum (Vietnam) Co., Ltd. had an FDA recall?
Yes. Rohto-Mentholatum (Vietnam) Co., Ltd. has 8 FDA recalls on record. The most recent started Jul 14, 2026.
Need more than this page shows? Ask about Rohto-Mentholatum (Vietnam) Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.